DXCM:NASDAQ
DexCom Inc
$84.30
arrow_upward
+1.09%(+0.91) 1D
$84.30
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DXCM...
Open
$83.80
High
$85.70
Low
$83.74
Mkt. cap
31.81B
Avg. vol.
3.77M
Volume
2.86M
P/E ratio
33.45
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.48
Shares outstanding
377.36M
No. of employees
11K
Open
$83.80
High
$85.70
Low
$83.74
Mkt. cap
31.81B
Avg. vol.
3.77M
Volume
2.86M
P/E ratio
33.45
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.48
Shares outstanding
377.36M
No. of employees
11K
News stories
From web sources and news partners
Simply Wall Street
·
8 hours ago
Should Type 2 Care Report Require Action From DexCom (DXCM) Investors?
GuruFocus
·
9 hours ago
DXCM Initiated Coverage by Barclays -- Rating Set to Overweight
Yahoo Finance
·
10 hours ago
Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4:30 p.m. Eastern Time
Quiver Quantitative
·
1 day ago
DexCom Falls as Investors Appear to Take Profits Ahead of Earnings
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com